Pharmaceutical sector set for 8-10% revenue growth in FY 25, …
WEB12 hours ago · Wednesday, September 18, 2024, 15:15 Hrs [IST] The Indian pharmaceuticals sector will log a revenue growth of 8-10 per cent this fiscal, after around 10 per cent growth last year, supported by healthy exports to regulated markets, recovery in exports to semi-regulated markets and steady domestic demand, according to a …
US FDA issues draft guidance on conducting multiregional clinical ...
WEB14 hours ago · Maryland. Wednesday, September 18, 2024, 14:00 Hrs [IST] The US Food and Drug Administration issued a draft guidance for industry that, when finalized, will provide sponsors with recommendations for conducting multiregional clinical trials (MRCT) in support of applications for drugs intended to treat cancer. An MRCT is …
Full-Life Technologies, SK Biopharma ink licensing agreement for …
WEB11 hours ago · Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement with SK Biopharmaceuticals, a global biotech company, for exclusive worldwide clinical research, development, manufacturing, and commercialization rights to ...
US FDA grants Emergency Use Authorization to Novavax 2024 …
WEBSep 2, 2024 · Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, announced the Novavax Covid-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for active immunization to ...
TopNews - Pharmabiz.com
WEBSep 9, 2024 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing.
Pfizer, BioNTech receive US FDA approval & authorization for …
WEBSaturday, August 24, 2024, 09:00 Hrs [IST] Pfizer Inc. and BioNTech SE announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY (Covid-19 Vaccine, mRNA), and granted emergency use authorization for individuals 6 …
News - Pharmabiz.com
WEB5 days ago · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing.
Pfizer, BioNTech provide update on mRNA-based combination …
WEBAug 17, 2024 · Pfizer Inc. and BioNTech SE announced top-line results from their phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and Covid-19 in healthy individuals 18-64 years of age. The combination candidate consists of Pfizer’s mRNA-based influenza ...
Boehringer Ingelheim’s Cyltezo to treat multiple chronic …
WEBFriday, May 3, 2024, 11:00 Hrs [IST] Boehringer Ingelheim Group, one of the largest producers of biologic medicines in the world, announced that the US Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of Cyltezo (adalimumab-adbm), the company's interchangeable biosimilar to Humira (adalimumab), to ...
AstraZeneca completes acquisition of clinical-stage biotech …
WEBJul 16, 2024 · Cambridge, UK. Tuesday, July 16, 2024, 10:00 Hrs [IST] AstraZeneca announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. The acquisition bolsters the Alexion, AstraZeneca Rare Disease late-stage pipeline and expands on ...
Skip to content